Rafferty Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $58.9M | Sell |
63,993
-25,388
| -28% | -$25.7M | 0.24% | 58 |
|
|
2025
Q4 | $96.1M | Sell |
89,381
-2,683
| -3% | -$2.57M | 0.33% | 47 |
|
|
2025
Q3 | $70.2M | Buy |
92,064
+7,154
| +8% | +$5.32M | 0.23% | 59 |
|
|
2025
Q2 | $66.2M | Buy |
84,910
+11,134
| +15% | +$8.65M | 0.22% | 63 |
|
|
2025
Q1 | $60.9M | Sell |
73,776
-16,034
| -18% | -$13.3M | 0.26% | 49 |
|
|
2024
Q4 | $69.3M | Buy |
89,810
+9,327
| +12% | +$7.72M | 0.25% | 55 |
|
|
2024
Q3 | $71.3M | Sell |
80,483
-6,811
| -8% | -$6.12M | 0.24% | 50 |
|
|
2024
Q2 | $79M | Buy |
87,294
+4,327
| +5% | +$3.46M | 0.29% | 48 |
|
|
2024
Q1 | $64.5M | Buy |
82,967
+1,103
| +1% | +$785K | 0.24% | 54 |
|
|
2023
Q4 | $47.7M | Sell |
81,864
-1,974
| -2% | -$1.15M | 0.2% | 57 |
|
|
2023
Q3 | $45M | Buy |
83,838
+6,828
| +9% | +$3.52M | 0.26% | 54 |
|
|
2023
Q2 | $36.1M | Buy |
77,010
+5,607
| +8% | +$2.35M | 0.2% | 60 |
|
|
2023
Q1 | $24.5M | Buy |
71,403
+2,731
| +4% | +$921K | 0.17% | 85 |
|
|
2022
Q4 | $25.1M | Buy |
68,672
+25,696
| +60% | +$9.11M | 0.21% | 79 |
|
|
2022
Q3 | $13.9M | Buy |
42,976
+23,044
| +116% | +$7.3M | 0.15% | 103 |
|
|
2022
Q2 | $6.46M | Sell |
19,932
-5,977
| -23% | -$1.79M | 0.06% | 243 |
|
|
2022
Q1 | $7.42M | Sell |
25,909
-4,327
| -14% | -$1.11M | 0.04% | 254 |
|
|
2021
Q4 | $8.35M | Buy |
30,236
+1,722
| +6% | +$437K | 0.04% | 230 |
|
|
2021
Q3 | $6.59M | Buy |
28,514
+9,018
| +46% | +$2.23M | 0.05% | 244 |
|
|
2021
Q2 | $4.47M | Buy |
19,496
+1,399
| +8% | +$281K | 0.03% | 349 |
|
|
2021
Q1 | $3.38M | Buy |
18,097
+221
| +1% | +$43.2K | 0.02% | 411 |
|
|
2020
Q4 | $3.02M | Buy |
17,876
+72
| +0.4% | +$10.8K | 0.03% | 346 |
|
|
2020
Q3 | $2.63M | Sell |
17,804
-4,003
| -18% | -$620K | 0.03% | 341 |
|
|
2020
Q2 | $3.58M | Buy |
21,807
+12,407
| +132% | +$1.9M | 0.05% | 234 |
|
|
2020
Q1 | $1.3M | Sell |
9,400
-26,123
| -74% | -$3.59M | 0.05% | 211 |
|
|
2019
Q4 | $4.67M | Buy |
35,523
+25,983
| +272% | +$3.01M | 0.07% | 142 |
|
|
2019
Q3 | $1.07M | Buy |
9,540
+3,874
| +68% | +$431K | 0.02% | 522 |
|
|
2019
Q2 | $628K | Buy |
5,666
+3,054
| +117% | +$360K | 0.01% | 642 |
|
|
2019
Q1 | $339K | Buy |
+2,612
| New | +$318K | 0.01% | 713 |
|
|
2018
Q4 | – | Sell |
-1,919
| Closed | -$206K | – | 679 |
|
|
2018
Q3 | $206K | Buy |
+1,919
| New | +$192K | ﹤0.01% | 676 |
|
|
2016
Q4 | – | Sell |
-8,071
| Closed | -$648K | – | 491 |
|
|
2016
Q3 | $648K | Buy |
+8,071
| New | +$646K | 0.02% | 294 |
|
|
2014
Q3 | – | Sell |
-9,246
| Closed | -$575K | – | 389 |
|
|
2014
Q2 | $575K | Buy |
+9,246
| New | +$552K | 0.11% | 130 |
|
Other funds holding LLY
VCM
VPM
Rafferty Asset Management's LLY Position: Q1 2026 in Review
Rafferty Asset Management reduced its Eli Lilly (LLY) stake by 28% in Q1 2026, selling an estimated $25.7M and leaving 63,993 shares worth $58.9M. The position accounts for 0.24% of the portfolio, ranked #58.
Rafferty Asset Management first reported a position in LLY in Q2 2014 and has held it in 32 quarters since. The position peaked at $96.1M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Rafferty Asset Management held 63,993 shares of Eli Lilly worth $58.9M as of Q1 2026.
- Rafferty Asset Management sold 25,388 Eli Lilly shares in Q1 2026, an estimated $25.7M.
- Eli Lilly made up 0.24% of Rafferty Asset Management's portfolio in Q1 2026, its #58 holding.
- Rafferty Asset Management first reported a position in Eli Lilly in Q2 2014 and has held it in 32 quarters since.
- Rafferty Asset Management's Eli Lilly position peaked at $96.1M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.